AutoICD API

72312-2

Laboratory

t(1;19)(q23.3;p13.3)(PBX1,TCF3) fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

Definition

A translocation involving chromosomes 1 and 19, t(1;19)(q23;p13), results in a fused transcript between TCF3 (formerly E2A) and PBX1 (formerly prl) genes. The TCF3-PBX1 fusion gene is found in approximately 3% of childhood and adult precursor-B acute lymphoblastic leukemia (ALL). This code is based on, but not limited to, Ispogen's E2A-PBX1 FusionQuant® kit, which uses real-time Quantitative RQ-PCR to quantify the expression level of specific TCF3(E2A)-PBX1 fusion gene transcripts relative to a control gene transcript (e.g. ABL1). From the manufacturer's website (2012), "Quantification of E2A-PBX1 fusion gene transcripts has been standardized in the EAC (Europe Against Cancer) program [Gabert J et al. Leukemia. 2003, Beillard E et al. Leukemia. 2003], and IPSOGEN FusionQuant® kits use this validated technology to calibrate and normalize RQ-PCR results."

LOINC 6-Axis Classification

Component

t(1;19)(q23.3;p13.3)(PBX1,TCF3) fusion transcript/control transcript

Property

NRto

Time Aspect

Pt

System

Bld/Tiss

Scale Type

Qn

Method Type

Molgen

Details

Class

MOLPATH.TRNLOC

Order/Observation

Both

Short Name

t(1;19)(PBX1,TCF3)/control Bld/T

Display Name

t(1;19)(q23.3;p13.3)(PBX1,TCF3) fusion transcript/control transcript Molgen (Bld/Tiss) [# ratio]

Related Names

ABLABL1ABL1 transcriptAcute lymphoblastic leukaemiaAcute lymphoblastic leukemiaAcute myeloid leukemiaALLAMLBloodcontrol geneDNAE2A Immunoglobulin enhancer binding factors E12/E47gene fusiongene translocationGeneticsHeredityHeritableiImmunoglobulin transcription factor 1InheritedITF1Molecular geneticsMolecular pathologyMOLPATHMOLPATH.TRANSLOCATIONNon-Hodgkin lymphomaNumber ratioPBXP1PCRPoint in timePre-B cell leukemia transcription factor-1QNTQuanQuantQuantitativeRandomRNAT primet(119)(PBX1,TCF3)TissueTissue, unspecifiedTranscription factor 3translocationWBWhole bloodWhole blood or Tissue

Frequently Asked Questions

What is LOINC code 72312-2?

LOINC code 72312-2 identifies "t(1;19)(q23.3;p13.3)(PBX1,TCF3) fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method". A translocation involving chromosomes 1 and 19, t(1;19)(q23;p13), results in a fused transcript between TCF3 (formerly E2A) and PBX1 (formerly prl) genes. The TCF3-PBX1 fusion gene is found in approximately 3% of childhood and adult precursor-B acute lymphoblastic leukemia (ALL). This code is based on, but not limited to, Ispogen's E2A-PBX1 FusionQuant® kit, which uses real-time Quantitative RQ-PCR to quantify the expression level of specific TCF3(E2A)-PBX1 fusion gene transcripts relative to a control gene transcript (e.g. ABL1). From the manufacturer's website (2012), "Quantification of E2A-PBX1 fusion gene transcripts has been standardized in the EAC (Europe Against Cancer) program [Gabert J et al. Leukemia. 2003, Beillard E et al. Leukemia. 2003], and IPSOGEN FusionQuant® kits use this validated technology to calibrate and normalize RQ-PCR results."

What does 72312-2 measure?

This code measures t(1;19)(q23.3;p13.3)(PBX1,TCF3) fusion transcript/control transcript in Bld/Tiss. It belongs to the MOLPATH.TRNLOC class in the LOINC classification.

What is LOINC?

LOINC (Logical Observation Identifiers Names and Codes) is a universal standard for identifying laboratory and clinical observations. It is maintained by the Regenstrief Institute and used worldwide for health data exchange.